Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12496285rdf:typepubmed:Citationlld:pubmed
pubmed-article:12496285lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:12496285lifeskim:mentionsumls-concept:C0555198lld:lifeskim
pubmed-article:12496285lifeskim:mentionsumls-concept:C0031715lld:lifeskim
pubmed-article:12496285lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:12496285lifeskim:mentionsumls-concept:C0248868lld:lifeskim
pubmed-article:12496285lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:12496285lifeskim:mentionsumls-concept:C1413357lld:lifeskim
pubmed-article:12496285lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:12496285lifeskim:mentionsumls-concept:C0769224lld:lifeskim
pubmed-article:12496285lifeskim:mentionsumls-concept:C1709059lld:lifeskim
pubmed-article:12496285lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:12496285lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:12496285lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:12496285pubmed:issue9lld:pubmed
pubmed-article:12496285pubmed:dateCreated2003-2-24lld:pubmed
pubmed-article:12496285pubmed:abstractTextFas, upon cross-linking with Fas ligand (FasL) or Fas agonistic antibody, transduces apoptotic yet also proliferative signals, which have been implicated in tumor pathogenesis. In this study, we investigated the molecular mechanisms that control Fas-mediated signaling in glioma cells. Fas agonistic antibody, CH-11, induced apoptosis in sensitive glioma cells through caspase-8 recruitment to the Fas-mediated death-inducing signaling complex (DISC) where caspase-8 was cleaved to initiate apoptosis through a systematic cleavage of downstream substrates. In contrast, CH-11 stimulated cell growth in resistant glioma cells through recruitment of c-FLIP (cellular Fas-associated death domain (FADD)-like interleukin-1beta-converting enzyme (FLICE)-inhibitory protein) to the Fas-mediated DISC. Three isoforms of long form c-FLIP were detected in glioma cells, but only the phosphorylated isoform was recruited to and cleaved into a p43 intermediate form in the Fas-mediated DISC in resistant cells. Calcium/calmodulin-dependent protein kinase II (CaMK II) activity was up-regulated in resistant cells. Treatment of resistant cells with the CaMK II inhibitor KN-93 inhibited CaMK II activity, reduced c-FLIP expression, inhibited c-FLIP phosphorylation, and rescued CH-11 sensitivity. Transfection of CaMK II cDNA in sensitive cells rendered them resistant to CH-11. These results indicated that CaMK II regulates c-FLIP expression and phosphorylation, thus modulating Fas-mediated signaling in glioma cells.lld:pubmed
pubmed-article:12496285pubmed:languageenglld:pubmed
pubmed-article:12496285pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:citationSubsetIMlld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12496285pubmed:statusMEDLINElld:pubmed
pubmed-article:12496285pubmed:monthFeblld:pubmed
pubmed-article:12496285pubmed:issn0021-9258lld:pubmed
pubmed-article:12496285pubmed:authorpubmed-author:KrammerPeter...lld:pubmed
pubmed-article:12496285pubmed:authorpubmed-author:HaoChunhaiClld:pubmed
pubmed-article:12496285pubmed:authorpubmed-author:RoaWilson HWHlld:pubmed
pubmed-article:12496285pubmed:authorpubmed-author:XiaoChangClld:pubmed
pubmed-article:12496285pubmed:authorpubmed-author:YangBao...lld:pubmed
pubmed-article:12496285pubmed:issnTypePrintlld:pubmed
pubmed-article:12496285pubmed:day28lld:pubmed
pubmed-article:12496285pubmed:volume278lld:pubmed
pubmed-article:12496285pubmed:ownerNLMlld:pubmed
pubmed-article:12496285pubmed:authorsCompleteYlld:pubmed
pubmed-article:12496285pubmed:pagination7043-50lld:pubmed
pubmed-article:12496285pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:meshHeadingpubmed-meshheading:12496285...lld:pubmed
pubmed-article:12496285pubmed:year2003lld:pubmed
pubmed-article:12496285pubmed:articleTitleCalcium/calmodulin-dependent protein kinase II regulation of c-FLIP expression and phosphorylation in modulation of Fas-mediated signaling in malignant glioma cells.lld:pubmed
pubmed-article:12496285pubmed:affiliationDepartment of Laboratory Medicine and Pathology and Oncology, University of Alberta, Edmonton, Alberta T6G 2S2, Canada.lld:pubmed
pubmed-article:12496285pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12496285pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:816entrezgene:pubmedpubmed-article:12496285lld:entrezgene
entrez-gene:8837entrezgene:pubmedpubmed-article:12496285lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12496285lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12496285lld:entrezgene
lhgdn:association:5411lhgdn:found_inpubmed-article:12496285lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12496285lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12496285lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12496285lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12496285lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12496285lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12496285lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12496285lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12496285lld:pubmed
More...